Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Vomiting/vomiting episode with traces of blood; Cardiac arrest; This is a spontaneous report downloaded from the regulatory authority-WEB [Regulatory authority number IT-MINISAL02-710856]. A contactable physician reported an 82-year-old female patient received the first dose of bnt162b2 (COMIRNATY), intramuscular administered on arm left on 01Apr2021 10:35 (Batch/Lot Number: ER9470; Expiration Date: 31Jul2021) as SINGLE DOSE for COVID-19 immunization. Medical history included arterial hypertension and sleep disorder (reported as sleeping). Concomitant medications included perindopril (PERINDOPRIL) taken for arterial hypertension and delorazepam (DELORAZEPAM) taken for sleep disorder (sleeping disorder) both taken since unknown therapy dates. On 02Apr2021 (reported as 24 hours after administration), the patient had vomiting episode with traces of blood. After access to the patient, she was transferred to perform esophago-gastro-duodenoscopy but died of the patient due to cardiac arrest on that same day of 02Apr2021. It was not reported if an autopsy was performed. The patient died due to vomiting and cardiac arrest. Sender''s comments: On 06Apr2021 request for a clinical report and if an autopsy examination was carried out. Reporter''s comment: death of the patient 24 hours after the administration of the vaccine. No follow-up attempts are possible. No further information is expected. ; Reporter''s Comments: death of the patient 24 hours after the administration of the vaccine.; Reported Cause(s) of Death: Vomiting/ vomiting episode with traces of blood; cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166